| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
12 Assessment of response in bone metastases from breast cancer
|
Coleman, R.
|
|
1995
|
4 |
1 |
p. 67-68
2 p.
|
artikel
|
| 2 |
17 Assessment of therapy by the serum markers - TPS and CA15-3 - related to the UICC criteria in breast cancer Stage IV
|
Jonsson, P.-E.
|
|
1995
|
4 |
1 |
p. 69-
1 p.
|
artikel
|
| 3 |
Atlas of breast cancer
|
Pinder, S.
|
|
1995
|
4 |
1 |
p. 74-
1 p.
|
artikel
|
| 4 |
Atlas of breast cancer
|
Kissin, M.W.
|
|
1995
|
4 |
1 |
p. 77-
1 p.
|
artikel
|
| 5 |
A woman's decision: Breast care, treatment and reconstruction
|
Stewart, J.B.
|
|
1995
|
4 |
1 |
p. 74-
1 p.
|
artikel
|
| 6 |
Bibliography of the breast
|
|
|
1995
|
4 |
1 |
p. B1-B14
nvt p.
|
artikel
|
| 7 |
Breast and chest wall reconstruction by latissimus dorsi myocutaneous flap (238 cases)
|
Abbes, M.
|
|
1995
|
4 |
1 |
p. 33-39
7 p.
|
artikel
|
| 8 |
Breast reconstruction after mastectomy
|
Codner, M.A.
|
|
1995
|
4 |
1 |
p. 4-10
7 p.
|
artikel
|
| 9 |
3 CA 15.3 determination in the follow-up of patients with breast cancer
|
Seregni, B.
|
|
1995
|
4 |
1 |
p. 64-65
2 p.
|
artikel
|
| 10 |
15 C-erbB2 oncoprotein in the serum of patients with breast cancer
|
Willsher, P.
|
|
1995
|
4 |
1 |
p. 68-69
2 p.
|
artikel
|
| 11 |
8 Clinical applications of CA15-3, MCA, CEA and CA125 in patients with breast carcinoma
|
Szymendera, J.J.
|
|
1995
|
4 |
1 |
p. 66-
1 p.
|
artikel
|
| 12 |
Comment on the EUSOMA Consensus Conference on breast screening
|
di Maggio, C.
|
|
1995
|
4 |
1 |
p. 71-72
2 p.
|
artikel
|
| 13 |
7 Comparison of tumour markers CEA, AFP, CA15-3, TPS and NEU in breast cancer diagnosis
|
Eskelinen, M.
|
|
1995
|
4 |
1 |
p. 65-66
2 p.
|
artikel
|
| 14 |
Deep vein thrombosis related to Formestane?
|
Williams, P.
|
|
1995
|
4 |
1 |
p. 71-
1 p.
|
artikel
|
| 15 |
4 Disseminated breast cancer: does early treatment prolong survival without symptoms?
|
Jäger, W.
|
|
1995
|
4 |
1 |
p. 65-
1 p.
|
artikel
|
| 16 |
Editorial Board
|
|
|
1995
|
4 |
1 |
p. IFC-
1 p.
|
artikel
|
| 17 |
Erratum
|
|
|
1995
|
4 |
1 |
p. 77-
1 p.
|
artikel
|
| 18 |
ESO monographs. Endocrine therapy of breast cancer VI
|
Robertson, J.F.R.
|
|
1995
|
4 |
1 |
p. 76-77
2 p.
|
artikel
|
| 19 |
5-fluorouracil, epirubicin and cyclophosphamide, as first-line cytotoxic chemotherapy for disseminated breast carcinoma. A phase II study
|
Carmo-Pereira, J.
|
|
1995
|
4 |
1 |
p. 44-47
4 p.
|
artikel
|
| 20 |
Gestrinone in mastalgia: a randomized double bind placebo controlled trial (The Breast 1994; 3: 90–93)
|
Peters, F.
|
|
1995
|
4 |
1 |
p. 72-73
2 p.
|
artikel
|
| 21 |
14 Gross cystic disease fluid protein (CP-15) identifies breast cancer bone metastases response to treatment as accurately as the tumour marker CA15-3
|
Bundred, N.J.
|
|
1995
|
4 |
1 |
p. 68-
1 p.
|
artikel
|
| 22 |
Guidelines for the pathological management of mammographically detected breast lesions
|
Zafrani, B.
|
|
1995
|
4 |
1 |
p. 52-56
5 p.
|
artikel
|
| 23 |
Immediate and delayed breast reconstruction with latissimus dorsi myocutaneous flap: consideration of aesthetic and functional results from an analysis of 50 cases
|
Modena, S.
|
|
1995
|
4 |
1 |
p. 40-43
4 p.
|
artikel
|
| 24 |
Influence of timing of surgery during menstrual cycle on survival of premenopausal women with operable breast cancer
|
Stonelake, P.S.
|
|
1995
|
4 |
1 |
p. 19-24
6 p.
|
artikel
|
| 25 |
Mammography quality control manual
|
Stickland, V.
|
|
1995
|
4 |
1 |
p. 74-
1 p.
|
artikel
|
| 26 |
Marie Curie conference report, 14–15 April 1994, Edinburgh. Do women in Scotland receive appropriate treatment for small breast cancer tumours?
|
|
|
1995
|
4 |
1 |
p. 57-61
5 p.
|
artikel
|
| 27 |
2 Markers for diagnosis
|
Blamey, R.W.
|
|
1995
|
4 |
1 |
p. 64-
1 p.
|
artikel
|
| 28 |
13 Osteolysis is mediated by humoral mechanisms in patients with breast cancer and bone metastases
|
Bundred, N.J.
|
|
1995
|
4 |
1 |
p. 68-
1 p.
|
artikel
|
| 29 |
Pathology of the breast
|
Elston, C.W.
|
|
1995
|
4 |
1 |
p. 74-75
2 p.
|
artikel
|
| 30 |
Percutaneous breast biopsy
|
Yeoman, L.
|
|
1995
|
4 |
1 |
p. 75-76
2 p.
|
artikel
|
| 31 |
1 Primary breast cancer — is there a role for tumour markers?
|
Robertson, J.F.R.
|
|
1995
|
4 |
1 |
p. 64-
1 p.
|
artikel
|
| 32 |
6 Primary tumour staining as a predictor of serum levels at diagnosis of metastases
|
Willsher, P.
|
|
1995
|
4 |
1 |
p. 65-
1 p.
|
artikel
|
| 33 |
10 Prospective confirmation of a biochemical response index
|
Robertson, J.F.R.
|
|
1995
|
4 |
1 |
p. 66-67
2 p.
|
artikel
|
| 34 |
Psychosocial adjustment of women with mastalgia
|
Ramirez, A.J.
|
|
1995
|
4 |
1 |
p. 48-51
4 p.
|
artikel
|
| 35 |
Reply
|
Wald, N.J.
|
|
1995
|
4 |
1 |
p. 72-
1 p.
|
artikel
|
| 36 |
Reply
|
Stein, R.C.
|
|
1995
|
4 |
1 |
p. 73-
1 p.
|
artikel
|
| 37 |
5 Structural and immunological features of carcinoma associated mucins
|
Price, M.R.
|
|
1995
|
4 |
1 |
p. 65-
1 p.
|
artikel
|
| 38 |
Surgical procedure can explain varying influence of menstrual cycle on prognosis of premenopausal breast cancer patients
|
von Minckwitz, G.
|
|
1995
|
4 |
1 |
p. 29-32
4 p.
|
artikel
|
| 39 |
The effects and costs of breast cancer screening
|
Chilvers, C.E.D.
|
|
1995
|
4 |
1 |
p. 75-
1 p.
|
artikel
|
| 40 |
9 The initial approach to tumour markers in guiding therapy
|
Blamey, R.W.
|
|
1995
|
4 |
1 |
p. 66-
1 p.
|
artikel
|
| 41 |
11 The Nottingham biochemical index (ESR, CEA, CA 15.3): a marker of therapeutic response in metastatic breast cancer and its potential role in rationalising breast cancer therapy
|
Dixon, A.R.
|
|
1995
|
4 |
1 |
p. 67-
1 p.
|
artikel
|
| 42 |
The role of serum tumour markers in breast cancer
|
|
|
1995
|
4 |
1 |
p. 62-63
2 p.
|
artikel
|
| 43 |
The timing of breast cancer surgery with respect to the menstrual cycle. More data which emphasize the need for a prospective study
|
Perren, T.J.
|
|
1995
|
4 |
1 |
p. 1-3
3 p.
|
artikel
|
| 44 |
The truth about breast implants
|
Watson, J.D.
|
|
1995
|
4 |
1 |
p. 76-
1 p.
|
artikel
|
| 45 |
Timing of breast cancer surgery during menstrual cycle. A 10-year analysis of 133 premenopausal women
|
D'eredita', G.
|
|
1995
|
4 |
1 |
p. 25-28
4 p.
|
artikel
|
| 46 |
16 TPS in breast cancer
|
Robertson, J.F.R.
|
|
1995
|
4 |
1 |
p. 69-
1 p.
|
artikel
|
| 47 |
18 Tumour markers vs UICC - the health economists view
|
Whynes, D.K.
|
|
1995
|
4 |
1 |
p. 69-70
2 p.
|
artikel
|
| 48 |
Type 1 growth factor receptors: an overview of recent developments
|
Mason, S.
|
|
1995
|
4 |
1 |
p. 11-18
8 p.
|
artikel
|
| 49 |
Ultrasound diagnosis of breast diseases
|
Wilson, A.R.M.
|
|
1995
|
4 |
1 |
p. 76-
1 p.
|
artikel
|
| 50 |
Vertical mammaplasty and liposuction
|
Dixon, J.M.
|
|
1995
|
4 |
1 |
p. 75-
1 p.
|
artikel
|
Tijdschrift beschrijving